Goffin L - Search Results

1

In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis.

Fineschi S, Bongiovanni M, Donati Y, Djaafar S, Naso F, Goffin L, Argiroffo CB, Pache JC, Dayer JM, Ferrari-Lacraz S, Chizzolini C. Fineschi S, et al. Among authors: goffin l. Am J Respir Cell Mol Biol. 2008 Oct;39(4):458-65. doi: 10.1165/rcmb.2007-0320OC. Epub 2008 May 5. Am J Respir Cell Mol Biol. 2008. PMID: 18458239

2

Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.

Fineschi S, Goffin L, Rezzonico R, Cozzi F, Dayer JM, Meroni PL, Chizzolini C. Fineschi S, et al. Among authors: goffin l. Arthritis Rheum. 2008 Dec;58(12):3913-23. doi: 10.1002/art.24049. Arthritis Rheum. 2008. PMID: 19035500 Free article.

3

Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts.

Goffin L, Seguin-Estévez Q, Alvarez M, Reith W, Chizzolini C. Goffin L, et al. Arthritis Res Ther. 2010;12(2):R73. doi: 10.1186/ar2991. Epub 2010 Apr 29. Arthritis Res Ther. 2010. PMID: 20429888 Free PMC article.

4

Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.

Goffin L, Fagagnini S, Vicari A, Mamie C, Melhem H, Weder B, Lutz C, Lang S, Scharl M, Rogler G, Chvatchko Y, Hausmann M. Goffin L, et al. Inflamm Bowel Dis. 2016 Sep;22(9):2041-57. doi: 10.1097/MIB.0000000000000863. Inflamm Bowel Dis. 2016. PMID: 27542125

5

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y. Vicari AP, et al. Among authors: goffin l. MAbs. 2017 Aug/Sep;9(6):927-944. doi: 10.1080/19420862.2017.1332553. Epub 2017 Jun 5. MAbs. 2017. PMID: 28581883 Free PMC article.

6

Erratum to: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model.

Aubry C, Michon C, Chain F, Chvatchko Y, Goffin L, Zimmerli SC, Leguin S, Langella P, Bermudez-Humaran L, Chatel JM. Aubry C, et al. Among authors: goffin l. Microb Cell Fact. 2016 Nov 10;15(1):188. doi: 10.1186/s12934-016-0592-6. Microb Cell Fact. 2016. PMID: 27832790 Free PMC article. No abstract available.

7

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.

Quartier P, Alexeeva E, Constantin T, Chasnyk V, Wulffraat N, Palmblad K, Wouters C, I Brunner H, Marzan K, Schneider R, Horneff G, Martini A, Anton J, Wei X, Slade A, Ruperto N, Abrams K; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group. Quartier P, et al. Arthritis Rheumatol. 2021 Feb;73(2):336-346. doi: 10.1002/art.41488. Epub 2020 Dec 11. Arthritis Rheumatol. 2021. PMID: 32783351 Free PMC article. Clinical Trial.

8

Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger.

Brogan PA, Hofer M, Kuemmerle-Deschner JB, Koné-Paut I, Roesler J, Kallinich T, Horneff G, Calvo Penadés I, Sevilla-Perez B, Goffin L, Lauwerys BR, Lachmann HJ, Uziel Y, Wei X, Laxer RM. Brogan PA, et al. Among authors: goffin l. Arthritis Rheumatol. 2019 Nov;71(11):1955-1963. doi: 10.1002/art.41004. Epub 2019 Sep 9. Arthritis Rheumatol. 2019. PMID: 31161734 Free PMC article. Clinical Trial.

9

Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model.

Aubry C, Michon C, Chain F, Chvatchenko Y, Goffin L, Zimmerli SC, Leguin S, Langella P, Bermudez-Humaran L, Chatel JM. Aubry C, et al. Among authors: goffin l. Microb Cell Fact. 2015 Nov 6;14:176. doi: 10.1186/s12934-015-0367-5. Microb Cell Fact. 2015. PMID: 26546058 Free PMC article.

10

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG. Ruperto N, et al. Among authors: goffin l. N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099. N Engl J Med. 2012. PMID: 23252526 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page